Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |